Prostate Cancer
Oncura Announces Exclusive Supply and Resale Agreement With Theragenics Corporation
Published in Clinical Oncology Week, July 26th, 2010
minimally invasive permanent prostate brachytherapy management of prostate cancer, has announced that it has signed an agreement to distribute Theragenics Corporation TheraSeed® palladium-103 brachytherapy seeds.
Under the terms of the agreement, Oncura will exclusively sell the TheraSeed palladium-103 seed, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada. The term of the agreement is through May 31, 2013 and provides for additional one-year terms upon mutual agreement of the parties.
"We are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Clinical Oncology
Data on clinical oncology reported by R. Kumar and co-researchers - Thyroid Cancer
Data on thyroid cancer published by researchers at National Institutes of Health - Adenoid Cystic Cancer
Findings in adenoid cystic cancer reported from Fujian Medical University - Synovial Sarcoma
Investigators at Kyushu University release new data on synovial sarcoma - Pancreatitis
Investigators at University of Bologna, Department of Clinical Medicine have published new data on pancreatitis - Carcinosarcoma
New data from University of Bari illuminate research in carcinosarcoma - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
